Headline
The latest stories from AHA Today.
FDA issued a reminder to health care facilities’ reprocessing staffs to follow the agency-outlined decontamination cycle when using the ASP STERRAD Sterilization System to decontaminate N95 or N95-equivalent respirators for reuse via vaporized hydrogen peroxide.
The FDA authorized the emergency use of certain personal protective equipment to help address insufficient supply due to the COVID-19 pandemic.
The House Education and Labor Committee’s Workforce Protections Subcommittee held a hearing examining federal actions to protect workers from COVID-19, which featured witnesses from the Occupational Safety and Health Administration and National Institute for Occupational Safety and Health.
The Federal Reserve has announced that it is establishing a Main Street Lending Program to support lending to small and medium-sized businesses that were in sound financial condition before the onset of the COVID-19 pandemic.
The Small Business Administration released an interim final rule to clarify Paycheck Protection Program loan forgiveness requirements, and the agency’s process for reviewing PPP loan applications and loan forgiveness applications.
In a near unanimous vote, the House of Representatives today passed the Paycheck Flexibility Act (H.R. 7010) to allow more leeway for small business loans during the COVID-19 crisis.
AHA's Health Research & Educational Trust has announced that Patrick Romano, M.D., co-editor-in-chief of Health Services Research Journal, will leave his position in June.
Community Health Improvement Week (June 1-5) celebrates people coming together to create healthier communities. And that's never been more important than now.
Thirty-four emerging hospital and health system leaders from 20 states will participate in the inaugural class of the AHA’s Next Generation Leaders Fellowship, working one-on-one with a mentor on a yearlong project to drive transformation and innovation to address a specific challenge at their…
Over 1,750 Medicare Part D prescription drug plans and Medicare Advantage plans with prescription drug coverage have applied to offer lower insulin costs through the Part D Senior Savings Model for the 2021 plan year, the Centers for Medicare & Medicaid Services said.